Search

Your search keyword '"Hulsman M"' showing total 82 results

Search Constraints

Start Over You searched for: Author "Hulsman M" Remove constraint Author: "Hulsman M"
82 results on '"Hulsman M"'

Search Results

1. New insights into the genetic etiology of Alzheimer's disease and related dementias

2. Mapping the genetic landscape of early-onset Alzheimer’s disease in a cohort of 36 families

4. New insights into the genetic etiology of Alzheimer's disease and related dementias

6. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

7. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

8. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (Acta Neuropathologica, (2019), 138, 2, (237-250), 10.1007/s00401-019-02026-8)

9. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (vol 138, pg 237, 2019)

10. Data integration strategies for bioinformatics with applications in biomarker and network discovery

11. Meta-Analysis on Blood Transcriptomic Studies Identifies Consistently Co-Expressed PPI Modules as Robust Markers of Human Ageing

12. Automated injection of slurry samples in flow-injection analysis

13. Doden tijdens een militaire missie

14. Data mining the TopoChip

20. Delineation of amplification, hybridization and location effects in microarray data yields better-quality normalization

21. PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment

22. The SORL1 p.Y1816C variant causes impaired endosomal dimerization and autosomal dominant Alzheimer's disease.

23. Cognitively healthy centenarians are genetically protected against Alzheimer's disease.

24. Connecting dementia risk loci to the CSF proteome identifies pathophysiological leads for dementia.

25. The correlation between neuropathology levels and cognitive performance in centenarians.

26. Resilience and resistance to the accumulation of amyloid plaques and neurofibrillary tangles in centenarians: An age-continuous perspective.

27. Cognition, function, and prevalent dementia in centenarians and near-centenarians: An individual participant data (IPD) meta-analysis of 18 studies.

29. Author Correction: Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.

30. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease.

31. Mapping the genetic landscape of early-onset Alzheimer's disease in a cohort of 36 families.

32. The Effect of Alzheimer's Disease-Associated Genetic Variants on Longevity.

33. Risk of dementia in APOE ε4 carriers is mitigated by a polygenic risk score.

34. Genome-wide association study of frontotemporal dementia identifies a C9ORF72 haplotype with a median of 12-G4C2 repeats that predisposes to pathological repeat expansions.

35. snpXplorer: a web application to explore human SNP-associations and annotate SNP-sets.

37. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.

38. Polygenic Risk Score of Longevity Predicts Longer Survival Across an Age Continuum.

39. Association of Cognitive Function Trajectories in Centenarians With Postmortem Neuropathology, Physical Health, and Other Risk Factors for Cognitive Decline.

40. Immune response and endocytosis pathways are associated with the resilience against Alzheimer's disease.

42. PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment.

43. Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

44. Longitudinal Maintenance of Cognitive Health in Centenarians in the 100-plus Study.

45. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.

46. Neuropsychological Test Performance of Cognitively Healthy Centenarians: Normative Data From the Dutch 100-Plus Study.

47. Centenarian controls increase variant effect sizes by an average twofold in an extreme case-extreme control analysis of Alzheimer's disease.

48. EIF2AK3 variants in Dutch patients with Alzheimer's disease.

49. The 100-plus Study of cognitively healthy centenarians: rationale, design and cohort description.

50. Neuropathology and cognitive performance in self-reported cognitively healthy centenarians.

Catalog

Books, media, physical & digital resources